Cargando…
The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
INTRODUCTION: Lambert–Eaton myasthenic syndrome (LEMS) is characterized by autoantibodies against voltage-gated calcium channels (VGCC) at the neuromuscular junction causing proximal muscle weakness, decreased tendon reflexes, and autonomic changes. The European LEMS registry aimed to collate observ...
Autores principales: | Meisel, Andreas, Sieb, Jörn P., Le Masson, Gwendal, Postila, Ville, Sacconi, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338181/ https://www.ncbi.nlm.nih.gov/pubmed/35511347 http://dx.doi.org/10.1007/s40120-022-00354-8 |
Ejemplares similares
-
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
por: Gilhus, Nils Erik
Publicado: (2011) -
Lambert-Eaton Myasthenic syndrome: early diagnosis is key
por: Ivanovski, Trajche, et al.
Publicado: (2019) -
Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
por: Bukhari, Sumera, et al.
Publicado: (2017)